Evidence map›Paper›PMID 31947655›Full record

ArticleMolecules (Basel, Switzerland)2020

A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine.

Ye Bi, Bingcong Lv, Lianlian Li, Robert J Lee, Jing Xie, Zhidong Qiu, Lesheng Teng

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ye BiKey Laboratory of Effective Components of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
Bingcong LvSchool of Life Sciences, Jilin University, Changchun 130117, China.
Lianlian LiSchool of Life Sciences, Jilin University, Changchun 130117, China.
Robert J LeeSchool of Life Sciences, Jilin University, Changchun 130117, China.
Jing XieSchool of Life Sciences, Jilin University, Changchun 130117, China.
Zhidong QiuKey Laboratory of Effective Components of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
Lesheng TengKey Laboratory of Effective Components of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
Jilin University · CNChangchun University of Chinese Medicine · CN

Funding

Engineering Research Center of Jilin Provincial Science and Technology Department 20170623055TC
6 · The paper itself

Abstract

Proliposomes were used to improve the solubility and oral bioavailability of nifedipine. Nifedipine proliposomes were prepared by methanol injection-spray drying method. The response surface method was used to optimize formulation to enhance the encapsulation efficiency (EE%) of nifedipine. The particle size of nifedipine proliposomes after rehydration was 114 nm. Surface morphology of nifedipine proliposomes was observed by a scanning electron microscope (SEM) and interaction of formulation ingredients was assessed by differential scanning calorimetry (DSC). The solubility of nifedipine is improved 24.8 times after forming proliposomes. In vitro release experiment, nifedipine proliposomes had a control release effect, especially in simulated gastric fluid. In vivo, nifedipine proliposomes significantly improved the bioavailability of nifedipine. The area under the concentration-time curve (AUC

Indexed as

Drug CompoundingDrug LiberationAdministration, OralAnimalsBiological AvailabilityChemistry, PharmaceuticalDrug CarriersDrug Delivery SystemsGastrointestinal TractLiposomesNifedipineRatsRats, WistarSolubilityVasodilator AgentsDrug CarriersLiposomesNifedipineVasodilator Agentsbioavailabilitynifedipinepharmacokineticsproliposomes

Identifiers

PMID31947655
PMCPMC7024191
OpenAlexW2998889154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.